Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 26, 2016 ) Neisseria meningitidis Infections - Pipeline Review, H1 2016
Summary
Global Markets Directs, Neisseria meningitidis Infections - Pipeline Review, H1 2016, provides an overview of the Neisseria meningitidis Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects.
Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=719512
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Click to submit Query/ Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=719512
Table of Contents
Table of Contents 2 List of Tables 7 List of Figures 8 Introduction 9 Global Markets Direct Report Coverage 9 Neisseria meningitidis Infections Overview 10 Therapeutics Development 11 Pipeline Products for Neisseria meningitidis Infections Overview 11 Pipeline Products for Neisseria meningitidis Infections Comparative Analysis 12 Neisseria meningitidis Infections Therapeutics under Development by Companies 13 Neisseria meningitidis Infections Therapeutics under Investigation by Universities/Institutes 14 Neisseria meningitidis Infections Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Neisseria meningitidis Infections Products under Development by Companies 18 Neisseria meningitidis Infections Products under Investigation by Universities/Institutes 19 Neisseria meningitidis Infections Companies Involved in Therapeutics Development 20 Beijing Minhai Biotechnology Co., Ltd 20 Beijing Tiantan Biological Products Co., Ltd. 21 Biological E. Limited 22 GlaxoSmithKline Plc 23 ImmunoBiology Limited 24 JN-International Medical Corporation 25
Contact Us:
Mr. Nachiket Albany NY - 12207 United States Tel: +1-518-621-2074 Tel: 866-997-4948 (Us-Canada Toll Free) Email: sales@researchmoz.us Latest Press-Releases: http://www.researchmoz.us/pressrelease
About ResearchMoz
ResearchMoz is the worlds fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMozs service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|